Genetic Resilience to the Clinical Manifestation of Dementia
Genetic Resilience to the Clinical Manifestation of Dementia
批准号:
9265741
负责人:
Timothy J Hohman
金额:
$11.91万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-05-03 至 2021-02-28
关键词:
Academic Medical CentersAgeAgingAlzheimer&aposs DiseaseAmyloid beta-ProteinApolipoprotein EArchitectureAreaAtlasesAttentionAttenuatedAutopsyAwardBioinformaticsBiologicalBlood VesselsBrainCerebrovascular DisordersClinicalCognitionCognitiveCognitive deficitsDataData SetDementiaEducationEmployee StrikesEnsureEnvironmentFoundationsFunctional disorderFundingFutureGene ExpressionGenesGeneticGenetic MarkersGenomicsGenotypeGenotype-Tissue Expression ProjectGoalsImpaired cognitionIndividualInfarctionInterventionLate Onset Alzheimer DiseaseLeast-Squares AnalysisMeasuresMemoryMentorsMentorshipMethodsModelingModernizationMolecularMolecular ProfilingNeurobehavioral ManifestationsNeurodegenerative DisordersPathologicPathologyPathway interactionsPerformancePhenotypePredictive FactorProtein KinaseRecording of previous eventsReligion and SpiritualityResearchResearch MethodologyResidual stateResourcesRisk FactorsScanningSenile PlaquesStatistical MethodsTechniquesTelomere PathwayTissue-Specific Gene ExpressionTrainingTraining ProgramsVariantVascular DementiaWorkbasebrain tissuecareercareer developmentcerebrovascularcerebrovascular healthcognitive reserveendophenotypeexperiencegenetic risk factorgenome wide association studyinnovationlipid transportneuroimagingneuropathologynovelprofessorpublic health relevanceresearch and developmentresilienceskillsstatisticstau Proteinstau aggregationtherapeutic targetwardwhole genome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This project will identify genetic factors that predict individual resilience to cognitive impairment arising from Alzheimer's disease (AD) or cerebrovascular disease. At autopsy, approximately 30% of cognitively normal individuals have the pathological features of AD or cerebrovascular disease. Yet, to date very little research has focused on the genetic factors that might contribute to such resilience. The objective of this project is to delineate the genetic architecture of asymptomatic AD. The identification of such novel genes will provide targets for clinical intervention aimed at activating natural biological defenses to neuropathology. This work will apply an innovative method to calculate predicted-gene-expression levels rather than relying solely on genome-wide association study (GWAS) analyses. I will also leverage 2 autopsy datasets: the National Alzheimer's Coordinating Center (n=882) and the Religious Orders Study/Memory and Aging Project (n=954). My mentorship team has extensive experience with these datasets and will provide expert guidance through the research methods and parallel training plan. My central hypothesis is that genetic effects will predict cognitive resilience to the damaging effects of AD and cerebrovascular pathologies. Based on this hypothesis, the primary aims of this application will identify and replicate genetic effects that (1) predict cognitive resilience to AD pathology, and (2) predict cognitive resilience
to cerebrovascular pathology. The complementary training plan will equip me with the skills necessary to build out an independent research career focused on genetic resilience by emphasizing the following training content areas: (1) neuropathology, (2) advanced bioinformatics to bridge the gap from genotype to gene expression, and (3) the clinical characterization of AD and vascular dementia. The mentor team is made up of experts in each of these content areas. Their expert training will be augmented by the interdisciplinary training program at the Vanderbilt Memory and Alzheimer's Center, and the cutting edge computational and genomic resources available at Vanderbilt University Medical Center. Together, these practical and intellectual resources provide the ideal training environment. My primary mentor, Dr. Angela Jefferson, has a strong funding history and all the financial and intellectual resources
needed to support my transition to independence. These extensive resources will allow me to dedicate 100% protected effort as an Assistant Professor to focus on research and career development. This will ensure that I am fully prepared to compete for independent funding (R01) over the course of the proposed award period.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biomarker Core
-
批准号:10038236
-
项目类别:
-
资助金额:$13.07万
-
财政年份:2020
-
负责人:Timothy J Hohman
-
依托单位:
Biomarker Core
-
批准号:10229541
-
项目类别:
-
资助金额:$15.51万
-
财政年份:2020
-
负责人:Timothy J Hohman
-
依托单位:
Biomarker Core
-
批准号:10909443
-
项目类别:
-
资助金额:$5.44万
-
财政年份:2020
-
负责人:Timothy J Hohman
-
依托单位:
Biomarker Core
-
批准号:10470724
-
项目类别:
-
资助金额:$15.74万
-
财政年份:2020
-
负责人:Timothy J Hohman
-
依托单位:
Neuroprotective Effects of Vascular Endothelial Growth Factor in Alzheimer's Disease
-
批准号:10362646
-
项目类别:
-
资助金额:$81.72万
-
财政年份:2019
-
负责人:Timothy J Hohman
-
依托单位:
Neuroprotective Effects of Vascular Endothelial Growth Factor in Alzheimer's Disease
-
批准号:10613404
-
项目类别:
-
资助金额:$80.8万
-
财政年份:2019
-
负责人:Timothy J Hohman
-
依托单位:
Neuroprotective Effects of Vascular Endothelial Growth Factor in Alzheimer's Disease
-
批准号:9883697
-
项目类别:
-
资助金额:$85.31万
-
财政年份:2019
-
负责人:Timothy J Hohman
-
依托单位:
Genetic Drivers of Resilience to Alzheimer's Disease
-
批准号:10431862
-
项目类别:
-
资助金额:$77.67万
-
财政年份:2018
-
负责人:Timothy J Hohman
-
依托单位:
Genetic Drivers of Resilience to Alzheimer's Disease
-
批准号:9577410
-
项目类别:
-
资助金额:$84.69万
-
财政年份:2018
-
负责人:Timothy J Hohman
-
依托单位:
Genetic Drivers of Resilience to Alzheimer's Disease
-
批准号:10207465
-
项目类别:
-
资助金额:$78.0万
-
财政年份:2018
-
负责人:Timothy J Hohman
-
依托单位:
Sex-Specific Genetic Drivers of Alzheimer's Disease Neuropathology
-
批准号:9766995
-
项目类别:
-
资助金额:$19.75万
-
财政年份:2018
-
负责人:Timothy J Hohman
-
依托单位:
Genetic Resilience to the Clinical Manifestation of Dementia
-
批准号:9272983
-
项目类别:
-
资助金额:$11.93万
-
财政年份:2016
-
负责人:Timothy J Hohman
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: